MYC and Miyoshi myopathy: Here we present evidence that miRNA-29a mediates PRIMA-1Met-induced cell death in MM by targeting c-Myc and that lipid-based delivery of miRNA-29a mimics displays substantial anti-myeloma activity in MM xenograft model, which synergizes with PRIMA-1Met.